Alnylam Pharmaceuticals, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2010 | 4.17x | $2.36 | $9.86 |
| Jun 2011 | 3.61x | $2.26 | $8.15 |
| Dec 2017 | 140.83x | $0.90 | $127.05 |
| Dec 2018 | 98.48x | $0.74 | $72.91 |
| Dec 2019 | 58.80x | $1.96 | $115.17 |
| Dec 2020 | 30.70x | $4.23 | $129.97 |
| Dec 2021 | 23.79x | $7.13 | $169.58 |
| Dec 2022 | 27.88x | $8.53 | $237.65 |
| Dec 2023 | 13.08x | $14.64 | $191.41 |
| Dec 2024 | 13.36x | $17.61 | $235.31 |
| Dec 2025 | 14.41x | $27.58 | $397.25 |